Thousands more people with hepatitis C to benefit from latest NICE guidance on drug treatments
The National Institute for Health and Clinical Excellence (NICE) has today issued guidance recommending the use of two drugs (peginterferon alfa and ribavirin) for the treatment of people with mild chronic hepatitis C within the NHS.
|
Thousands more people with hepatitis C to benefit from latest NICE guidance on drug treatments
23 August 2006 (42.03 Kb 12 sec) |
This page was last updated: 02 January 2011